#154 Alpha Score 87.3

moodywriter13

@moodywriter13 · tracked since Mar 2023
154
BUZZBERG The leaderboard is ranked by Alpha Score, which weighs a speaker's average return, their number of calls, and reputation — a credibility rating of the source that can only raise a score, never lower it. Read the FAQ
Alpha Score 87.3
Calls
9
Win Rate
44.4%
return
+20.1%
Calls 9 1958 Posts tracked · 1.6/day Posted today
Calls
7d 1
30d 2
90d 2
Best Calls
QURE Long +272.6%
CLPT Long +4.0%
CPH.TO Long +2.5%
Worst Calls
VKTX Long -48.2%
CPNG Long -21.6%
CAF.V Long -16.0%
Most Mentioned
CPH.TO ×10
MOB.ST ×6
CLPT ×3
Recent Calls
QURE Long 1 year ago
CLPT Long 1 year ago
CPH.TO Long 1 year ago
Win Rate 44% Long 9 Short 0
Win Rate
7d 0%
30d 0%
90d 0%
Average Return +20.1% Long Return +20.1% Short Return -
Average Return
7d -8.5%
30d -5.4%
90d -4.7%
Loading charts...
Result
Result
Sort
Theme Stance
Ticker
Side
Mentions
First Call
Call Price
P&L
Thesis
Theme
Source
Long
Jan 31
$13.76
+2.5%
Upcoming earnings to reflect recent acquisition
Expects the stock to re-rate as a growth stock once its latest acquisition is reflected in upcoming quarterly figures.
Pharma & Biotech
Long
Sep 13
$12.00
-11.5%
US monetization and 3x upside potential remain.
Author remains highly bullish on Moberg Pharma, citing guaranteed US monetization for MOB-015 and estimating over 3x upside potential even excluding the US market.
Pharma & Biotech
Long
Mar 02
$13.15
+272.6%
Promising data drives likely FDA approvals
Author bought QURE and is bullish on this basket of biotech names, citing very promising clinical data and a high likelihood of FDA approvals within the next 1-2 years.
Pharma & Biotech
Long
Feb 27
$14.91
+4.0%
Buying the dip for $1B market cap
Author is buying the post-call dip, projecting that the company will eventually reach a one billion dollar market capitalization.
MedTech
Long
Jul 30
$57.65
-2.5%
Strong order intake highlights cheap valuation
Calls the stock the cheapest way to invest in the theme following strong H1 order intake of €479.4 million.
Grid Equipment
Long
Jul 08
$0.38
-16.0%
Cash-rich microcap trades at massive FCF yield
Recommends buying this cash-rich microcap trading at a massive free cash flow yield with a pristine, debt-free balance sheet.
Coal
Long
Jun 04
$65.40
-48.2%
High buyout probability for best-in-class obesity therapy.
Expects a high probability of a buyout for VKTX, driven by its best-in-class obesity and NASH clinical trials and the massive sales potential in the GLP-1 market.
GLP-1 / Obesity
Long
Aug 21
$85.20
+1.6%
Long SGN.WA to 100-105 PLN fair value
Long SGN.WA for further upside to 100-105 PLN base-case fair value; the recent 20% move without news validates the overlooked-value thesis in a Polish software compounder with tiny free float and no analyst coverage, despite strong H1 revenue/profit growth.
AI Software
Long
Jan 30
$20.97
-21.6%
Moat and valuation drive Coupang long thesis
Author bought Coupang, citing its strong moat and attractive current valuation as drivers for a solid return over a 3-5 year period.
Retail & Mobility
Showing 9 of 9 calls · sorted by mentions

moodywriter13 has 9 trade ideas tracked on Buzzberg across 9 tickers since March 2023. Ranked #154 on the Buzzberg Alpha leaderboard. Most covered: CPH.TO, MOB.ST, CLPT.